Overall rank by patents
#25,896
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, active 2024–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G06T (IMAGE DATA PROCESSING OR GENERATION, IN GENERAL).
The verdict
Belletorus holds 10 US patents across 5 technology areas, rank #25,896 of 50,000 tracked assignees.
Belletorus Corporation has been granted 10 US utility patents between 2024 and 2025, placing Belletorus Corporation at rank #25,896 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.0 claims per patent with primary concentration in G06T (IMAGE DATA PROCESSING OR GENERATION, IN GENERAL). As a US Corporation, Belletorus Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Belletorus sits between Beijing Shunzao Technology Co., Ltd. (10 patents, rank #25,892) and Beteiligungen Sorg Gmbh & Co. KG (10 patents, rank #25,900) - the closest US assignees by grant volume. The composite Innovation Score of 48.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2024 through 2025, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Belletorus Corporation's 20.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Belletorus Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Beijing Shunzao Technology Co., Ltd.
10 patents
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
10 patents
Bell Laboratories, Inc.
10 patents
Bellco S.R.L.
10 patents
Bend Labs, Inc.
10 patents
Besser Company
10 patents
Bestop Baja, LLC
10 patents
Beteiligungen Sorg GmbH & Co. KG
10 patents
BelleTorus Corporation
10 patents
What this shows Belletorus holds 10 patents at rank #25,896, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Belletorus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 6 | 60.0% |
| 2025 | 4 | 40.0% |
Top 5 of 5 technology areas
Overall rank by patents
#25,896
Across all tracked assignees
48.2 out of 100
How to use this portfolio
Belletorus's 10 grants land it in the top 17% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.